PSL Glass Filter Dryer - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

PSL Glass Filter Dryer

The GFD® is changing the filtration and drying process in laboratories worldwide. In 2010, the GFD technology was launched combining filtration, cake washing and drying all in one glass vessel.

Working as a miniature agitated nustche filter dryer, this technology allows laboratory development simulating the manufacturing process at a small scale. When the filtration and drying process is validated during R&D, direct scale up is possible first through the three different sizes of GFD then with industrial metallic vessel during pilot plant and commercial production.

In little more than the 3 years since launch over many companies have already adopted this technology worldwide. Applications range from API filtration, peptides washing and drying, simulation for future industrial application, filtration and drying of different deposits sensitive to air or moisture, and most recently microsphere filtration.

Microspheres are small spherical particles, having a required size range. These particles can be manufactured from various natural and synthetic materials such as polymer microspheres. Suspended microspheres obtained from various micro encapsulation processes require being washed, collected by filtration then dried under appropriate conditions to give the final free flowing injectable product. After the process development phase performed with a GFD, direct scale-up is available with PSL Microsphere Refiner product range.

Website: www.powdersystems.com
E-mail: saleseu@powdersystems.com
T: +44 (0)151 448 7700
Stand location: Hall 4.1 Stand J50

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
29%
Breakthrough designations
10%
Protecting the supply chain
43%
Expedited reviews of drug submissions
10%
More stakeholder involvement
10%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
FindPharma Custom Search

Click here